Nayas Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 05-11-2024
- Paid Up Capital ₹ 2.25 Cr
as on 05-11-2024
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.90 Cr
as on 05-11-2024
About Nayas Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹6.90 Cr.
Krishna Kuchipudi, Kuchipudi Vanaja, Koti Tiyyagura, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290TG2022PTC167401
- Company No.
167401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2022
- Date of AGM
08 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nayas Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeevan Kuchipudi  | Managing Director | 05-Jul-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Koti Tiyyagura | Whole-Time Director | 05-Jul-2023 | Current |
| Krishna Kuchipudi | Director | 11-Oct-2022 | Current |
| Kuchipudi Vanaja | Director | 11-Oct-2022 | Current |
Financial Performance of Nayas Laboratories.
Nayas Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nayas Laboratories?
In 2023, Nayas Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jeevan Scientific Technology LimitedActive 25 years 10 monthsKrishna Kuchipudi and Jeevan Kuchipudi are mutual person
Jeevana Mitra Constructions LlpActive 5 years 4 monthsKrishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Naya Pharma Private LimitedActive 4 years 4 months
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Jstl Pharmaceutical Private LimitedActive 2 years 16 days
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Apr 2023 | ₹6.90 Cr | Open |
How Many Employees Work at Nayas Laboratories?
Unlock and access historical data on people associated with Nayas Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nayas Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nayas Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
